These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 28901378

  • 1. Androgen-independent LNCaP cells are a subline of LNCaP cells with a more aggressive phenotype and androgen suppresses their growth by inducing cell cycle arrest at the G1 phase.
    Yu P, Duan X, Cheng Y, Liu C, Chen Y, Liu W, Yin B, Wang X, Tao Z.
    Int J Mol Med; 2017 Nov; 40(5):1426-1434. PubMed ID: 28901378
    [Abstract] [Full Text] [Related]

  • 2. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S, Nayak S, Fernandes G, Barai RS, Menon S, Chaudhari UK, Kholkute SD, Sachdeva G.
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway.
    Li X, Li T, Chen D, Zhang P, Song Y, Zhu H, Xiao Y, Xing Y.
    Oncol Rep; 2016 Jan; 35(1):584-92. PubMed ID: 26534764
    [Abstract] [Full Text] [Related]

  • 4. Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.
    Won SH, Lee HJ, Jeong SJ, Lü J, Kim SH.
    Phytother Res; 2012 May; 26(5):669-74. PubMed ID: 21997969
    [Abstract] [Full Text] [Related]

  • 5. ErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cells.
    Muniyan S, Chen SJ, Lin FF, Wang Z, Mehta PP, Batra SK, Lin MF.
    Cell Signal; 2015 Nov; 27(11):2261-71. PubMed ID: 26257301
    [Abstract] [Full Text] [Related]

  • 6. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
    Dulinska-Litewka J, McCubrey JA, Laidler P.
    Curr Med Chem; 2013 Nov; 20(1):144-57. PubMed ID: 23033951
    [Abstract] [Full Text] [Related]

  • 7. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM, Hay N, Liao S.
    Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
    [Abstract] [Full Text] [Related]

  • 8. CA916798 affects growth and metastasis of androgen-dependent prostate cancer cells.
    He J, Lan X, Duan HL, Luo H, Zhou XD.
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4477-4487. PubMed ID: 30058677
    [Abstract] [Full Text] [Related]

  • 9. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE, Shin JS, Leem DG, Kim SD, Cho WJ, Lee KT.
    Chem Biol Interact; 2016 Dec 25; 260():196-207. PubMed ID: 27720946
    [Abstract] [Full Text] [Related]

  • 10. Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cells.
    Lin HP, Lin CY, Hsiao PH, Wang HD, Jiang SS, Hsu JM, Jim WT, Chen M, Kung HJ, Chuu CP.
    PLoS One; 2013 Dec 25; 8(12):e82625. PubMed ID: 24349321
    [Abstract] [Full Text] [Related]

  • 11. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
    Shiota M, Itsumi M, Takeuchi A, Imada K, Yokomizo A, Kuruma H, Inokuchi J, Tatsugami K, Uchiumi T, Oda Y, Naito S.
    Endocr Relat Cancer; 2015 Dec 25; 22(6):889-900. PubMed ID: 26311513
    [Abstract] [Full Text] [Related]

  • 12. Androgen receptor represses the neuroendocrine transdifferentiation process in prostate cancer cells.
    Wright ME, Tsai MJ, Aebersold R.
    Mol Endocrinol; 2003 Sep 25; 17(9):1726-37. PubMed ID: 12775765
    [Abstract] [Full Text] [Related]

  • 13. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
    Iwasa Y, Mizokami A, Miwa S, Koshida K, Namiki M.
    Int J Urol; 2007 Mar 25; 14(3):233-9. PubMed ID: 17430262
    [Abstract] [Full Text] [Related]

  • 14. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity.
    Chen C, Shao R, Li B, Zhai Y, Wang T, Li X, Miao L, Huang J, Liu R, Liu E, Zhu Y, Gao X, Zhang H, Wang Y.
    Phytomedicine; 2021 May 25; 85():153514. PubMed ID: 33676083
    [Abstract] [Full Text] [Related]

  • 15. [Expression and regulation of androgen receptor in the androgen-independent conversion of prostate cancer cells].
    Wang HF, Liu WJ, Jin J, Zhou LQ, Liang LL, Wang Y, Guo YL.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug 18; 43(4):490-5. PubMed ID: 21844951
    [Abstract] [Full Text] [Related]

  • 16. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
    Tsui KH, Chung LC, Feng TH, Chang PL, Juang HH.
    Int J Cancer; 2012 Jun 15; 130(12):2812-23. PubMed ID: 21780100
    [Abstract] [Full Text] [Related]

  • 17. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes.
    Olsen JR, Azeem W, Hellem MR, Marvyin K, Hua Y, Qu Y, Li L, Lin B, Ke X, Øyan AM, Kalland K.
    BMC Cancer; 2016 Jul 04; 16():377. PubMed ID: 27378372
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models.
    Zhang ZB, Ip SP, Cho WC, Hu Z, Huang YF, Luo DD, Xian YF, Lin ZX.
    J Ethnopharmacol; 2020 Oct 05; 260():113058. PubMed ID: 32525068
    [Abstract] [Full Text] [Related]

  • 19. FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription.
    Liu Y, Liu Y, Yuan B, Yin L, Peng Y, Yu X, Zhou W, Gong Z, Liu J, He L, Li X.
    Oncotarget; 2017 Mar 07; 8(10):17027-17037. PubMed ID: 28199985
    [Abstract] [Full Text] [Related]

  • 20. MiR-221 promotes the development of androgen independence in prostate cancer cells via downregulation of HECTD2 and RAB1A.
    Sun T, Wang X, He HH, Sweeney CJ, Liu SX, Brown M, Balk S, Lee GS, Kantoff PW.
    Oncogene; 2014 May 22; 33(21):2790-800. PubMed ID: 23770851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.